[AI20]Life Science Large Model
Hiro-LS API supports inquiries related to the pharmaceutical competitive landscape, clinical trials and evidence-based medicine, sequence/compound patents, as well as policies and regulartions issues. The biopharmaceutical large model (Hiro-LS) aims to perform intelligent retrieval, analysis, and data mining in response to these questions, providing continuously evolving biopharmaceutical information to create limitless opportunities for exploration in life sciences.
Request Parameters
List of parameters supported by this API endpoint
| Name | Type | Example | Description |
|---|---|---|---|
Required | string | What are the indications for siRNA drugs? | User question
Note: No more than 500 character. |
| string | 5bac8720937e4b77a5b98df98033dc37 | Session ID is a unique identifier used to identify a single conversation or a multi-turn dialogue.
Note: When multiple rounds of dialogue are required, this field is a mandatory parameter. The session_id from the previous round of dialogue and the query for the second round must be included as input parameters. |
Response Schema
Structure of the API response data
| Field Name | Type | Example | Description |
|---|---|---|---|
data | object | - | response data |
output | object | Please check the form: AiPharmGptOutPut | Return Data |
usage | object | Please check the form: AiPatGptUsage | Measurement information indicating the consumption of metered data for this request |
input_tokens | integer<int32> | 20 | The length of the user's question after tokenization. |
total_tokens | integer<int32> | 1520 | The total length of tokens consumed after the model invocation is complete. |
output_tokens | integer<int32> | 1500 | The length of the text generated by the model after tokenization. |
status | string | finished | Model Return Status
Note:
When status = "running", the system is outputting via SSE,
When status = "finished", the request has ended,
When status = "length", the generated content exceeds the model's maximum length. |
content | string | siRNA drugs, or small interfering RNA drugs, are a class of medications that use RNA interference (RNAi) to silence specific genes. This silencing can prevent the production of disease-causing proteins or reduce their levels. The indications for siRNA drugs are diverse and have been developed for various diseases and conditions. Here are some examples of indications for siRNA drugs based on the information provided:\n\n1. **Primary Hyperoxaluria Type 1**: Drugs like Nedosiran and Lumasiran sodium are indicated for this rare genetic disorder characterized by the excessive production of a substance called oxalate, leading to kidney damage and other issues.\n\n2. **Thromboembolism and Kidney Failure, Chronic**: SR-059 is indicated for conditions related to blood clotting and chronic kidney failure.\n\n3. **Amyloidosis, Hereditary, Transthyretin-Related**: Vutrisiran Sodium and Patisiran sodium are used to treat a type of hereditary amyloidosis caused by transthyretin (TTR) protein aggregation.\n\n4. **Hyperlipoproteinemia Type II and Atherosclerosis**: Inclisiran sodium is indicated for managing high levels of certain types of cholesterol and atherosclerosis, a condition characterized by the buildup of fats, cholesterol, and other substances in and on the artery walls.\n\n5. **Atherosclerosis**: Several other drugs like Lepodisiran sodium, Olpasiran, Zerlasiran, and Kylo-11 are also indicated for atherosclerosis, which involves the narrowing or blockage of coronary arteries due to plaque buildup.\n\n6. **Hypertriglyceridemia and Dyslipidemias**: Plozasiran and BW-00112 are indicated for conditions related to high levels of triglycerides and abnormal lipid levels in the blood.\n\n7. **Dyslipidemias**: Several drugs such as Zodasiran, VSA-003, RP-910, and others are indicated for managing dyslipidemias, which involve abnormal levels of lipids (e.g., cholesterol, triglycerides) in the blood.\n\n8. **Hyperlipidemia, Familial Combined and Primary hypercholesterolemia**: SYH2053 and YKYY-015 are indicated for these conditions related to high levels of lipids in the blood.\n\n9. **Metabolic Diseases and Hypercholesterolemia**: JS401 is indicated for metabolic diseases and high cholesterol levels.\n\n10. **Hyperlipidemias**: RBD-5044 is indicated for managing high levels of lipids in the blood.\n\n11. **Diabetes Mellitus, Type 2**: ALN-KHK and ARO-INHBE are indicated for type 2 diabetes, a chronic condition characterized by high blood sugar levels.\n\n12. **Hyperlipoproteinemias**: Solbinsiran Sodium is indicated for this condition, which involves high levels of lipids in the blood.\n\nThese indications reflect the broad application of siRNA technology in targeting specific pathways involved in various diseases, offering a promising approach to disease treatment by directly silencing the genes responsible for disease-causing proteins. | Conversation result |
references | array | Please check the form: RefdocInfo | Cited literature
Note: Only when status = "finished" will the request end and return the cited literature content, that is ref_doc, |
link | string | https://synapse.patsnap.com/drug/b7de1abb409c406788910307008b91ca | Hyperlink |
text | string | Nedosiran | Related text |
type | string | synapse | Text type |
index | integer<int32> | 2 | Corresponding index number, indicating the sequence number of the GPT-generated text for that reference |
doc_id | string | b7de1abb409c406788910307008b91ca | Citation ID |
doc_type | string | drug_dev_status | Literature type |
post_date | integer<int32> | 20200522 | Publication date of the literature |
text_summary | string | | Summary of the related text |
session_id | string | ebc4a867-9a75-4611-99b8-32e44706226e | Session ID, which is a unique identifier for a single or multiple rounds of dialogue |
statusRequired | boolean | false | Status |
error_msg | string | The request parameter format is incorrect! | Error Message |
error_codeRequired | integer | 0 | Error Code |
Success Response Example
Example of a successful API response
{
"data": {
"output": {
"usage": {
"input_tokens": 20,
"total_tokens": 1520,
"output_tokens": 1500
},
"status": "finished",
"content": "冷冻消融球囊是一种用于医疗治疗的设备,主要应用于心脏手术中的消融程序,尤其是心律失常如心房颤动的治疗。这种设备通常包含一个可膨胀的球囊,球囊内部可以流通一种特殊的冷却介质,通过热传导的方式将低温传递给目标组织,从而实现组织的冷冻消融。\\n冷冻消融球囊的技术和设计在不断进步,以下是一些相关的专利和文献,展示了不同方面的创新和改进:\\n\\n球囊材料和结构的改进:\\n[3] 描述了一种用于血管内导管系统的冷冻球囊,由特定比例的聚氨酯和聚酰胺嵌段共聚物形成。这种材料配比使得球囊在较低压力下能实现较大的尺寸调节性,同时保持良好的机械性能。\\n球囊尺寸和压力调节:\\n[4] 提供了一种球囊尺寸可调的冷冻消融系统及方法,通过控制部件中的充气管路和球囊流量压力控制管路,实现对球囊尺寸和压力的精确调节,从而提高治疗的安全性和有效性。\\n多叶球囊设计:\\n[5] 揭示了一种用于冷冻消融的多叶球囊设计。这种设计包括多个独立的球囊瓣叶,可以通过独立的流体输送管腔进行膨胀,适用于更复杂的组织结构消融,如心脏的复杂形状。\\n温度和压力控制:\\n[7] 介绍了一种冷冻消融仪球囊内压力动态平衡系统,通过控制单元、数据采集单元和压力调节单元实现对球囊内压力的实时调节,确保消融过程中的温度和压力在理想的范围内。\\n无创定位技术:\\n[6] 公开了一种心房颤动消融冷冻球囊无创定位装置,通过电极阵列进行球囊定位,避免了使用有害射线,提高了手术的安全性和定位的准确性。\\n接触压力评估:\\n[8] 描述了一种评估冷冻球囊消融导管接触压力的方法。通过在消融过程中记录和比较球囊的压力测量值与预定压力阈值,确保球囊与目标组织的有效接触,从而提高消融效果。\\n这些创新和改进使得冷冻消融球囊技术更加精细和安全,为患者提供了更好的治疗效果。",
"references": [
{
"link": "https://synapse.patsnap.com/drug/b7de1abb409c406788910307008b91ca",
"text": "融术,手术历时1小时,取得成功。术后,患者发作性心悸的症状得以缓解。球囊冷冻消融,是通过导管传递液态氮氧化物至末端球囊,将液态氮氧化物转化为气态,使周围组织遇冷,从而达到消融效果。这部分气体会从回收真空腔返回。球囊冷冻消融通过组织遇冷导致细胞内形成晶体,使细胞膜破坏,细胞内的代谢及电活动不能正常进行。另外,通过对微血管的破环使局部血流灌注减少,同样可以使细胞死亡,发挥肺静脉隔离的作用,从而根治阵发性心房颤动。房颤的冷冻消融术相对于射频消融术来说,有其独特的优势所在:1) 可操作性较强,不需要复杂的三维建模和逐点消融,大大节省了手术时间。2) 疗效确切,成功率高,单次手术成功率可达到80-90%以上。3) 并发症少,尤其是食管瘘,心包填塞等并发症,较射频消融术大大降低,安全性高。4)",
"type": "synapse",
"index": 2,
"doc_id": "b7de1abb409c406788910307008b91ca",
"doc_type": "drug_dev_status",
"post_date": 20200522,
"text_summary": "秦皇岛市第一医院心血管内科二病区成功完成我市首例房颤冷冻消融术"
}
],
"session_id": "ebc4a867-9a75-4611-99b8-32e44706226e"
}
},
"status": true,
"error_code": 0
}Error Codes
List of possible error codes returned by this endpoint
Business Errors
| Error Code | Description |
|---|---|
68300004 | Invalid parameter! |
68300005 | Search api failure! |
68300006 | Analytic basic access error! |
68300007 | Bad request! |
68300008 | Service error, please try again later! |
68300010 | The file does not comply with upload specifications! |
Platform Errors
| Error Code | Description |
|---|---|
67200000 | API call exceeds the total limit set by the platform! |
67200001 | API call exceeds the total limit set by the platform! |
67200002 | The current call rate is too fast, exceeding the current configuration limit QPS! |
67200003 | The key and secret parameters for applying for the token are incorrect or the client has been disabled! |
67200004 | The requested api does not have permission. Please contact our support personnel! |
67200005 | Insufficient account balance/number of calls! |
67200006 | The client has exceeded the activation validity period! |
67200007 | The current call exceeds the configured usage limit of the day! |
67200008 | Please check if the required apikey in the query parameter has been transmitted! |
67200009 | The apikey does not match the passed bearerToken. Please check if a valid token is being used! |
67200012 | The request is illegal! |
67200100 | The current server status is busy, request response timeout! |
67200101 | The API requested currently does not exist. Please check the request path! |
HTTP Status Codes
| Status Code | Description |
|---|---|
0 | Success |
33610400 | Illegal content in user input |
33610500 | Illegal content in the returned results of the model |
33610600 | Internal system exception |
Performance Metrics
Expected performance characteristics for this endpoint
Normal Response Time
5000 ms
Max Response Time
10000 ms